Compare $PHIO vs $XCUR | Chartloom

Compare

$PHIO vs $XCUR

Phio Pharmaceuticals Corp · Exicure Inc

PHIO

Phio Pharmaceuticals Corp

XCUR

Exicure Inc

Compare $PHIO vs $XCUR

Comparing Phio Pharmaceuticals Corp and Exicure Inc

PHIOPhio Pharmaceuticals Corp

XCURExicure Inc

PHIOPhio Pharmaceuticals Corp

Market cap

$11M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-10.2%

52W performance

-59.6%

FCF yield

-107.3%

XCURExicure Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-81.2%

52W performance

-80.3%

FCF yield

-105.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PHIO

XCUR

Detailed metrics comparison

PHIO

Phio Pharmaceuticals Corp

XCUR

Exicure Inc

Market Cap

PHIO$11M

XCUR$7M

Enterprise Value

PHIO$-2M

XCUR$5M

Price

PHIO$0.98

XCUR$1.05

P/E Ratio

PHION/A

XCURN/A

P/S Ratio

PHIO81.74x

XCUR14.24x

EV/Sales

PHIO-11.08x

XCUR10.81x

EV/EBITDA

PHIO0.00x

XCUR0.90x

P/B Ratio

PHIO0.91x

XCUR7.29x

P/FCF Ratio

PHION/A

XCURN/A

EV/FCF

PHIO0.13x

XCUR-0.71x

PEG Ratio

PHION/A

XCURN/A

Forward P/E (NTM)

PHION/A

XCURN/A

Forward P/S (NTM)

PHION/A

XCURN/A

Revenue (TTM)

PHIO$0

XCUR$0

Revenue Growth (YoY)

PHION/A

XCURN/A

Forward Rev Growth

PHIO0.0%

XCUR0.0%

Gross Margin (TTM)

PHIO0.0%

XCUR0.0%

Operating Margin (TTM)

PHIO0.0%

XCUR0.0%

EBITDA Margin (TTM)

PHIO0.0%

XCUR0.0%

Net Margin (TTM)

PHIO0.0%

XCUR0.0%

FCF Margin (TTM)

PHION/A

XCURN/A

Net Income (TTM)

PHIO$-13M

XCUR$-8M

FCF (TTM)

PHIO$-12M

XCUR$-7M

EPS (TTM)

PHIO-$1.11

XCUR-$1.30

ROE (TTM)

PHIO-8741.0%

XCUR-23791.0%

ROA (TTM)

PHIO-7976.0%

XCUR-6198.0%

ROIC (TTM)

PHIO-8741.0%

XCUR-23791.0%

Cash

PHIO$13M

XCUR$2M

Debt

PHIO$0

XCUR$0

Net Cash/Debt

PHIO$13M

XCUR$2M

Current Ratio (TTM)

PHIO8.39x

XCUR0.56x

Quick Ratio (TTM)

PHIO7.62x

XCUR0.43x

Debt/Equity (TTM)

PHIO0.00x

XCUR0.00x

Debt/Assets (TTM)

PHIO0.0%

XCUR0.0%

Interest Coverage (TTM)

PHION/A

XCURN/A

Net Debt/EBITDA (TTM)

PHIO0.00x

XCUR0.00x

Beta

PHIO0.90

XCUR3.86

52W Performance

PHIO-59.6%

XCUR-80.3%

YTD Performance

PHIO-10.2%

XCUR-81.2%

% from 52W High

PHIO-76.6%

XCUR-88.9%

% from 52W Low

PHIO20.8%

XCUR12.2%

Asset Turnover (TTM)

PHIO0.02x

XCUR0.05x

FCF Yield (TTM)

PHIO-107.3%

XCUR-105.0%

Earnings Yield (TTM)

PHIO-113.5%

XCUR-123.9%

Dividend Yield (TTM)

PHION/A

XCURN/A

Rule of 40

PHIO0.0

XCUR0.0

EV/GP/RG

PHION/A

XCURN/A

Ticker research

View PHIO research View XCUR research

Metric	PHIO Phio Pharmaceuticals Corp	XCUR Exicure Inc
Market & Valuation
Market Cap	$11M	$7M
Enterprise Value	$-2M	$5M
Price	$0.98	$1.05
P/E Ratio	N/A	N/A
P/S Ratio	81.74x	14.24x
EV/Sales	-11.08x	10.81x
EV/EBITDA	0.00x	0.90x
P/B Ratio	0.91x	7.29x
P/FCF Ratio	N/A	N/A
EV/FCF	0.13x	-0.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-13M	$-8M
FCF (TTM)	$-12M	$-7M
EPS (TTM)	-$1.11	-$1.30
ROE (TTM)	-8741.0%	-23791.0%
ROA (TTM)	-7976.0%	-6198.0%
ROIC (TTM)	-8741.0%	-23791.0%
Financial Health
Cash	$13M	$2M
Debt	$0	$0
Net Cash/Debt	$13M	$2M
Current Ratio (TTM)	8.39x	0.56x
Quick Ratio (TTM)	7.62x	0.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.90	3.86
52W Performance	-59.6%	-80.3%
YTD Performance	-10.2%	-81.2%
% from 52W High	-76.6%	-88.9%
% from 52W Low	20.8%	12.2%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.05x
FCF Yield (TTM)	-107.3%	-105.0%
Earnings Yield (TTM)	-113.5%	-123.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View PHIO research	View XCUR research

Valuation

P/S Ratio

XCUR

14.24x

PHIO

81.74x

EV/FCF

XCUR

-0.71x

PHIO

0.13x

Growth & revenue

Forward Revenue Growth

PHIO

0.0%

XCUR

0.0%

Profitability & performance

Gross Margin

PHIO

0.0%

XCUR

0.0%

ROE

PHIO

-8741.0%

XCUR

-23791.0%

FCF Yield %

XCUR

-105.0%

PHIO

-107.3%

52-Week Performance

PHIO

-59.6%

XCUR

-80.3%

Detailed metrics comparison

PHIO

Phio Pharmaceuticals Corp

XCUR

Exicure Inc

Market Cap

PHIO$11M

XCUR$7M

Enterprise Value

PHIO$-2M

XCUR$5M

Price

PHIO$0.98

XCUR$1.05

P/E Ratio

PHION/A

XCURN/A

P/S Ratio

PHIO81.74x

XCUR14.24x

EV/Sales

PHIO-11.08x

XCUR10.81x

EV/EBITDA

PHIO0.00x

XCUR0.90x

P/B Ratio

PHIO0.91x

XCUR7.29x

P/FCF Ratio

PHION/A

XCURN/A

EV/FCF

PHIO0.13x

XCUR-0.71x

PEG Ratio

PHION/A

XCURN/A

Forward P/E (NTM)

PHION/A

XCURN/A

Forward P/S (NTM)

PHION/A

XCURN/A

Revenue (TTM)

PHIO$0

XCUR$0

Revenue Growth (YoY)

PHION/A

XCURN/A

Forward Rev Growth

PHIO0.0%

XCUR0.0%

Gross Margin (TTM)

PHIO0.0%

XCUR0.0%

Operating Margin (TTM)

PHIO0.0%

XCUR0.0%

EBITDA Margin (TTM)

PHIO0.0%

XCUR0.0%

Net Margin (TTM)

PHIO0.0%

XCUR0.0%

FCF Margin (TTM)

PHION/A

XCURN/A

Net Income (TTM)

PHIO$-13M

XCUR$-8M

FCF (TTM)

PHIO$-12M

XCUR$-7M

EPS (TTM)

PHIO-$1.11

XCUR-$1.30

ROE (TTM)

PHIO-8741.0%

XCUR-23791.0%

ROA (TTM)

PHIO-7976.0%

XCUR-6198.0%

ROIC (TTM)

PHIO-8741.0%

XCUR-23791.0%

Cash

PHIO$13M

XCUR$2M

Debt

PHIO$0

XCUR$0

Net Cash/Debt

PHIO$13M

XCUR$2M

Current Ratio (TTM)

PHIO8.39x

XCUR0.56x

Quick Ratio (TTM)

PHIO7.62x

XCUR0.43x

Debt/Equity (TTM)

PHIO0.00x

XCUR0.00x

Debt/Assets (TTM)

PHIO0.0%

XCUR0.0%

Interest Coverage (TTM)

PHION/A

XCURN/A

Net Debt/EBITDA (TTM)

PHIO0.00x

XCUR0.00x

Beta

PHIO0.90

XCUR3.86

52W Performance

PHIO-59.6%

XCUR-80.3%

YTD Performance

PHIO-10.2%

XCUR-81.2%

% from 52W High

PHIO-76.6%

XCUR-88.9%

% from 52W Low

PHIO20.8%

XCUR12.2%

Asset Turnover (TTM)

PHIO0.02x

XCUR0.05x

FCF Yield (TTM)

PHIO-107.3%

XCUR-105.0%

Earnings Yield (TTM)

PHIO-113.5%

XCUR-123.9%

Dividend Yield (TTM)

PHION/A

XCURN/A

Rule of 40

PHIO0.0

XCUR0.0

EV/GP/RG

PHION/A

XCURN/A

Ticker research

View PHIO research View XCUR research

Metric	PHIO Phio Pharmaceuticals Corp	XCUR Exicure Inc
Market & Valuation
Market Cap	$11M	$7M
Enterprise Value	$-2M	$5M
Price	$0.98	$1.05
P/E Ratio	N/A	N/A
P/S Ratio	81.74x	14.24x
EV/Sales	-11.08x	10.81x
EV/EBITDA	0.00x	0.90x
P/B Ratio	0.91x	7.29x
P/FCF Ratio	N/A	N/A
EV/FCF	0.13x	-0.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-13M	$-8M
FCF (TTM)	$-12M	$-7M
EPS (TTM)	-$1.11	-$1.30
ROE (TTM)	-8741.0%	-23791.0%
ROA (TTM)	-7976.0%	-6198.0%
ROIC (TTM)	-8741.0%	-23791.0%
Financial Health
Cash	$13M	$2M
Debt	$0	$0
Net Cash/Debt	$13M	$2M
Current Ratio (TTM)	8.39x	0.56x
Quick Ratio (TTM)	7.62x	0.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.90	3.86
52W Performance	-59.6%	-80.3%
YTD Performance	-10.2%	-81.2%
% from 52W High	-76.6%	-88.9%
% from 52W Low	20.8%	12.2%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.05x
FCF Yield (TTM)	-107.3%	-105.0%
Earnings Yield (TTM)	-113.5%	-123.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View PHIO research	View XCUR research